LUIS GARZON: Open Payments
NPI 1710026588 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 38 payments from 21 companies in 2025. Trend: 2023 $65 · 2024 $319 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $148 |
| SANOFI-AVENTIS U.S. LLC | 4 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| ABBVIE INC. | 3 | $59 |
| Insulet Corporation | 1 | $58 |
| Amneal Pharmaceuticals LLC | 3 | $49 |
| VIVUS LLC | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $41 |
Products named: TZIELD, ZEPBOUND, MOUNJARO, Kerendia, Omnipod, UNITHROID, PANCREAZE, GVOKE HYPOPEN.
Industry payments across FL — which companies pay providers there.
